Use of biosimilars could increase if stakeholders, from manufacturers to payors and pharmacists, united to employ all the tools at their disposal, an expert told attendees of the 2021 virtual annual meeting of the Academy of Managed Care Pharmacy (AMCP).
Hospitals and health systems that have taken part in comprehensive approaches to biosimilar utilization report enjoying full adoption of biosimilar use and saving millions of dollars every year,